Armin Braun, a plant geneticist in the 1950-60's at the Rockefeller, was the first to provide experimental evidence for tumor reversion in plants. 1 Through setting up his experiments in plants, Braun made of tumor reversion a philogenetically conserved system. With today's understanding of the tumor cell plasticity, pluripotentiality and stemness, Braun of Arabidopsis thaliana was rescued by Drosophila TCTP and vice versa. Thus TCTP seems to integrate signals controlling cell cycle progression, proliferation and cell sizing. Brioudes et al. provide considerable insight into these issues through analysis of the first TCTP-lacking adult multicellular organisms. Moreover, this study may provide a missing link with early studies by Armin Braun.
Knocking down Arabidopsis TCTP slows down the cell cycle; G 1 -phase, when cells grow, is significantly prolonged (4 hrs) and M-phase entry is reduced. Does TCTP integrate cell sizing into the cell cycle machinery? If yes, it acts both on the S-and M-phase via downregulation of specific markers: PCNA for S-and cyclin B for M-phase. In animal cells TCTP also associates with F-actin fibers at the cell periphery, regulating cell shape both in interphase and in mitosis and cell motility. 6 This interaction may likely be assured through the TCTP cofilin-like domain. 7 On the other hand, the localization of TCTP to the mitotic spindle does not seem to implicate a direct association with microtubules. 6 Hence, TCTPcytoskeleton interaction becomes elusive and clearly requires more detailed analysis.
Genetic experiments in Drosophila linked TCTP to the TOR pathway. 8 Our data futher indicate that TCTP associates with the protein synthesis-initiation and -elongation machinery. 3 We found that besides interacting with eEF1A, it may also interact with the eIF3 complex (unpublished results), which is under the control of mTOR, as shown by John Blenis' work, 9 providing hereby a potential alternative molecular explanation for the genetic TCTP-TOR connection. TCTP also regulates the expression of oct4 and nanog, early embryonic genes, in nuclear reprogramming, as shown by John Gurdon's group. 10 Thus, TCTP seems more than ever to act on multiple pathways, making simultaneously numerous imprints on cell physiology. This may predispose TCTP to be an omnipresent factor able not only to drive, but also to assist efficiently major cell functions.
With the clear understanding that plant tumors are very different from human ones, nevertheless, to explore to what extend some pathways are conserved, an "easy experiment" would be to test whether silencing of TCTP could revert tumor formation in plants. Conversely, could forced expression of plant TCTP transform our revertants back into aggressive tumor cells? We would have at least some molecular explanations for Braun's results.
